113 related articles for article (PubMed ID: 18718658)
1. Aggressive characteristics of myeloblasts expressing CD7 in myelodysplastic syndromes.
Satoh C; Tamura H; Yamashita T; Tsuji T; Dan K; Ogata K
Leuk Res; 2009 Feb; 33(2):326-31. PubMed ID: 18718658
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of CD7 and terminal deoxynucleotidyl transferase (TdT) expression in CD34+ myeloblasts from patients with myelodysplastic syndrome.
Font P; Subirá D; Mtnez-Chamorro C; Castañón S; Arranz E; Ramiro S; Gil-Fernández JJ; López-Pascual J; Alonso A; Pérez-Sáenz MA; Alaez C; Renedo M; Blas C; Escudero A; Fdez-Rañada JM
Leuk Res; 2006 Aug; 30(8):957-63. PubMed ID: 16417922
[TBL] [Abstract][Full Text] [Related]
3. Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: a multicenter validation study.
Ogata K; Kakumoto K; Matsuda A; Tohyama K; Tamura H; Ueda Y; Kurokawa M; Takeuchi J; Shibayama H; Emi N; Motoji T; Miyazaki Y; Tamaki H; Mitani K; Naoe T; Sugiyama H; Takaku F
Leuk Res; 2012 Oct; 36(10):1229-36. PubMed ID: 22682984
[TBL] [Abstract][Full Text] [Related]
4. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
5. Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes.
Ogata K; Mochimaru Y; Sei K; Kawahara N; Ogata M; Yamamoto Y
PLoS One; 2023; 18(9):e0291662. PubMed ID: 37729123
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic analysis of myelodysplastic syndromes.
Del Cañizo MC; Fernández ME; López A; Vidriales B; Villarón E; Arroyo JL; Ortuño F; Orfao A; San Miguel JF
Haematologica; 2003 Apr; 88(4):402-7. PubMed ID: 12681967
[TBL] [Abstract][Full Text] [Related]
7. [Effect of IL-15 on the proliferation and differentiation of CD34+ cells from MDS patients].
Ye ZL; Chen MZ; Chen RL; Cheng WM; Huang XL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):106-9. PubMed ID: 15629097
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of novel myeloid precursor cell line, PC-MDS, established from a bone marrow of the patient with therapy-related myelodysplastic syndrome.
Bogdanović G; Jurisić V; Kraguljac N; Mrdjanović J; Jakimov D; Krtolica K; Krajnović M; Magić Z; Stojiljković B; Andrijević L; Srdić T; Baltić M; Popović S
Leuk Res; 2007 Aug; 31(8):1097-1105. PubMed ID: 17350682
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD7 in myelodysplastic syndromes (MDS): is this a truly prognostic factor?
Font P; Subirá D
Leuk Res; 2008 Jan; 32(1):185-6. PubMed ID: 17383724
[No Abstract] [Full Text] [Related]
10. A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia.
Cheung AM; Chow HC; Liang R; Leung AY
Br J Haematol; 2009 Feb; 144(4):484-91. PubMed ID: 19055666
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells.
Span LF; Vierwinden G; Pennings AH; Boezeman JB; Raymakers RA; de Witte T
Exp Hematol; 2005 Apr; 33(4):435-42. PubMed ID: 15781334
[TBL] [Abstract][Full Text] [Related]
12. A partial nucleated differential cell count of the bone marrow aspirate that is independent of peripheral blood dilution.
Lee SH; Ho SJ; Thomas DT; Giri P; Lee H; Sia H; To LB; Sullivan TR
Int J Lab Hematol; 2008 Dec; 30(6):473-9. PubMed ID: 18983299
[TBL] [Abstract][Full Text] [Related]
13. [Quantitative Analysis on Immunophenotype of CD34
Chen X; Ren FG; Zhang YF; Xu J; Xia T; Chang JM; Chen XH; Tan YH; Wang HW; Xu ZF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):832-839. PubMed ID: 34105480
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts.
Mufti GJ; Bennett JM; Goasguen J; Bain BJ; Baumann I; Brunning R; Cazzola M; Fenaux P; Germing U; Hellström-Lindberg E; Jinnai I; Manabe A; Matsuda A; Niemeyer CM; Sanz G; Tomonaga M; Vallespi T; Yoshimi A;
Haematologica; 2008 Nov; 93(11):1712-7. PubMed ID: 18838480
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin is a specific marker for erythroid differentiation and has utility, in combination with CD117 and CD34, for enumerating myeloblasts in hematopoietic neoplasms.
Ohgami RS; Chisholm KM; Ma L; Arber DA
Am J Clin Pathol; 2014 May; 141(5):656-64. PubMed ID: 24713736
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic flow cytometry for low-grade myelodysplastic syndromes.
Ogata K
Hematol Oncol; 2008 Dec; 26(4):193-8. PubMed ID: 18412289
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndromes: the complexity of stem-cell diseases.
Corey SJ; Minden MD; Barber DL; Kantarjian H; Wang JC; Schimmer AD
Nat Rev Cancer; 2007 Feb; 7(2):118-29. PubMed ID: 17251918
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K2 induces apoptosis of a novel cell line established from a patient with myelodysplastic syndrome in blastic transformation.
Nishimaki J; Miyazawa K; Yaguchi M; Katagiri T; Kawanishi Y; Toyama K; Ohyashiki K; Hashimoto S; Nakaya K; Takiguchi T
Leukemia; 1999 Sep; 13(9):1399-405. PubMed ID: 10482991
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes.
Satoh C; Dan K; Yamashita T; Jo R; Tamura H; Ogata K
Leuk Res; 2008 May; 32(5):699-707. PubMed ID: 17936901
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients.
Mazzella FM; Smith D; Horn P; Cotelingam JD; Rector JT; Shrit MA; Pesce A; Schumacher HR
Am J Hematol; 2006 Jul; 81(7):484-91. PubMed ID: 16755568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
